These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 9670422)
1. Medical science and clinical trials. Yonekura S Tokai J Exp Clin Med; 1997 Dec; 22(6):244-55. PubMed ID: 9670422 [No Abstract] [Full Text] [Related]
2. Ethical issues in pediatric trials. Ross LF; Newburger JW; Sanders SP Am Heart J; 2001 Aug; 142(2):233-6. PubMed ID: 11479460 [No Abstract] [Full Text] [Related]
3. Study population selection. Treiman DM Epilepsy Res Suppl; 1993; 10():125-35. PubMed ID: 8251088 [No Abstract] [Full Text] [Related]
4. Medical research on humans: regulation in Switzerland, the European Union, and the United States. Schott M Food Drug Law J; 2005; 60(1):45-77. PubMed ID: 15940854 [No Abstract] [Full Text] [Related]
5. [Ethics of clinical experimentation. Informed consent and ethics committees]. Dominici A Clin Ter; 1990 Sep; 134(5):273-6. PubMed ID: 2149309 [No Abstract] [Full Text] [Related]
6. Cancer drug approval in the United States, Europe, and Japan. Milsted RA Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686 [No Abstract] [Full Text] [Related]
7. Interview with Gary L. Yingling, J.D. Yingling GL Qual Manag Health Care; 1999; 7(3):45-7. PubMed ID: 10537462 [No Abstract] [Full Text] [Related]
8. European investigational antiepilepsy drug trials. Sussman NM Epilepsy Res Suppl; 1993; 10():149-55. PubMed ID: 8251090 [No Abstract] [Full Text] [Related]
9. [Therapeutic trial, clinical research and therapeutic freedom--legal boundaries]. Deutsch E Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):698-700; discussion 701. PubMed ID: 9527472 [TBL] [Abstract][Full Text] [Related]
11. [EEC recommendations concerning drug trials in humans]. Roscam Abbing HD Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2124-5. PubMed ID: 2247167 [No Abstract] [Full Text] [Related]
12. To market, to market. The nuts and bolts of prescription drug approval. Peterson AM Adv Nurse Pract; 2001 Apr; 9(4):87-90. PubMed ID: 12420443 [No Abstract] [Full Text] [Related]
13. Regulatory expectation for data on viral testing and process evaluation for phase I studies and product licensing in the United States, Europe and Japan. Moriguchi H Dev Biol Stand; 1996; 88():143-7. PubMed ID: 9119127 [No Abstract] [Full Text] [Related]
14. [Good clinical practice; the revised recommendations for Europe]. Keppel Hesselink JM Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2152-5. PubMed ID: 2247176 [No Abstract] [Full Text] [Related]
16. Performing phase I clinical trials of anticancer agents: perspectives from within the European union and Japan. Forster MD; Saijo N; Seymour L; Calvert H Clin Cancer Res; 2010 Mar; 16(6):1737-44. PubMed ID: 20215555 [TBL] [Abstract][Full Text] [Related]
17. Science and regulatory rituals associated with the drug development process. Versteegh LR Food Drug Law J; 1997; 52(2):155-61. PubMed ID: 10557552 [No Abstract] [Full Text] [Related]
18. [The inspection by the Danish Medical Products Agency of drug clinical trials]. Jacobsen E; Stilbo I Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822 [TBL] [Abstract][Full Text] [Related]
19. Development of medicines for children in Europe: ethical implications. Saint Raymond A; Brasseur D Paediatr Respir Rev; 2005 Mar; 6(1):45-51. PubMed ID: 15698816 [TBL] [Abstract][Full Text] [Related]
20. Clinical trials. Ventilator study gets second wind. Malakoff D Science; 2003 Jul; 301(5630):149. PubMed ID: 12855776 [No Abstract] [Full Text] [Related] [Next] [New Search]